May 17, 2020

Forest Laboratories dips post quarterly loss beats estimates

third-quarter loss
sale of newer drugs
branded forms of et
2 min
Forest Laboratories dips post quarterly loss beats estimates
Forest Laboratories Inc Thursday said it has posted a third-quarter loss wider than expected by the analysts. The drugmaker fell 1.3% to $37.11 at 9:45...

Forest Laboratories Inc Thursday said it has posted a third-quarter loss wider than expected  by the analysts. The drugmaker fell 1.3% to $37.11 at 9:45 a.m. New York time, after falling to $36.20 in the biggest intraday drop since Oct 16.

The loss in the period ended Dec. 31 was 21 cents a share after one-time items were excluded, the  New York-based drug maker said. The results compared with an 8-cent loss that was the average of 23 analyst’s expectations.

The sales of the drugmaker dipped 42% to $678 million, missing the $774 million estimate of analysts.

The revenue of the company has been declining after protection ended on the antidepressant Lexapro, once it biggest-seller with more than $2 billion in annual sales.

The company is pushing to offset the decline with sale of newer drugs, including the lung treatment Tudorza and bowel disorder medicine Linzess.

An analyst said, “The bottom-line is that we view these near-term numbers as not overly meaningful as the focus remains on management’s ability to launch Tudorza and Linzess.” Its shares gained 22% in the 12 months through yesterday.

The company said it expects full-year profit at lower end of its forecast of 45 cents to 60 cents a share. The revenue may be $3.1 billion, the company said.

Forest Laboratories, Inc develops, manufactures and sells branded forms of ethical drug products, most of which require a physician’s prescription. 

Share article

Jun 17, 2021

Dexcom: changing the lives of people with type 1 diabetes

3 min
British actress Nina Wadia OBE tells us how her son's life has changed since using glucose monitoring system Dexcom

It is estimated that 9.3% of adults around the world are living with type 1 diabetes, which amounts to a total of 463 million people. A further 1.1 million children and adolescents under the age of 20 are living with the condition. 

Unlike the more prevalent type 2 diabetes, where the body still produces insulin and symptoms develop slowly, people with type 1 diabetes need regular insulin injections or pumps, and must monitor their sugar levels frequently. 

In recent years a number of remote glucose monitoring systems have become available that patients can use at home. These work with a sensor, usually placed under the skin, that measures glucose levels every few minutes. This information is then transmitted wirelessly to a device like a smartphone or tablet, which can then be shared with their clinician. 

British actress Nina Wadia's son Aidan, 14, has type 1 diabetes, and has been managing his condition using Dexcom, a glucose monitoring system used by patients all over the world. Here Wadia explains how Dexcom has improved their lives. 

As a parent of someone with type 1 diabetes, what is your day-to-day life like?
Being able to take a breath, think and pivot constantly without getting frustrated becomes an essential mindset because sometimes it feels like each day is determined to be different from the day before. Whatever worked yesterday is going to misfire today. 

Which areas of yours and Aidan’s life are most impacted by diabetes? 
The one thing that you have to fight hard to reclaim is spontaneity, especially when it comes to food and exercise. It’s only when this is taken do you realise how essential each one is. You can be flexible and there are no real limits, but only in the sense that a great athlete can be flexible without limits because they’ve trained super hard to be that way. So we’ve all had to become athletes when it comes to being spontaneous.

How has Dexcom helped you and Aidan? 
Dexcom has brought future science fiction to real life today. The continuous glucose monitoring system is tiny, sits discreetly on his body and gives him a ten-day breather between sensor changes, so it's goodbye finger-pricking seven times daily. 

Dexcom is totally active at a grass roots level and for Diabetes Awareness has pledged to donate £2,000 if #DexcomDiabetesStories and/or #DexcomWarriorStories is shared 200 times! I’ll be sharing more on social media and would love to hear how other families are winning their fights.

Maybe most importantly Dexcom is trying to introduce a reimbursement programme for type 1 diabetes  patients which will give greater access to modern, life changing hi-tech. I want to spread the word on the importance of accessing it through this campaign. 

If you compared your life today with how it was before Aidan was using Dexcom, what has changed? 
It's always working, which lets him take his mind off diabetes for longer stretches. It also lets me get off his back. We both receive alerts so I no longer have to pester him by asking him what his number is, and especially importantly, I don’t have to wake him at night to prick his finger if I’m worried. Dexcom gave us back our sleep!

Share article